Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 22.7% in November

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a significant growth in short interest in November. As of November 15th, there was short interest totalling 351,100 shares, a growth of 22.7% from the October 31st total of 286,200 shares. Based on an average daily trading volume, of 668,200 shares, the days-to-cover ratio is presently 0.5 days.

Aethlon Medical Stock Up 3.4 %

Shares of NASDAQ:AEMD opened at $0.41 on Friday. The company has a market cap of $5.75 million, a PE ratio of -0.15 and a beta of 1.74. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.35. The firm has a 50-day simple moving average of $0.40 and a 200 day simple moving average of $0.43.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AEMD. HC Wainwright reiterated a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a research report on Friday, November 15th. StockNews.com started coverage on shares of Aethlon Medical in a report on Sunday, November 24th. They issued a “sell” rating for the company.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.